Tablet formulation

Details Tablet formulation Tablet formulation

1976-03-15

1976-12-14

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

424362, A61J 310, A61K 900

Patent

active

RE0290769

ABSTRACT:
The disclosure is directed to formulations for tablets which are to be deeply grooved to facilitate breaking into predetermined portions by the user. A critical tablet weight for deeply grooved tablets is disclosed.

REFERENCES:
patent: D91644 (1934-03-01), Blackstone
patent: D201497 (1965-06-01), Ninger
patent: D202467 (1965-10-01), Guilmot
patent: 1836604 (1931-12-01), Meyer
patent: 3146168 (1964-08-01), Battista
patent: 3336200 (1967-08-01), Krauss et al.
patent: 3723614 (1973-03-01), Langaver
Reier et al., J. Pharm. Sci. 55(5): 510-514 (1966) "Microcrystalline Cellulose in Tabletting."
Reier Dissertation Abstr. 25(5) 2933 (1964), "Microcrystalline Cellulose in Tabletting."
Fox et al., Cosmetic Ind. 92: 161-164, 258-261 (1963), "Microcrystalline Cellulose in Tabletting."
Battista et al., Ind. Eng. Chem. 54(9): 20-29 (1962), "Microcrystalline Cellulose."
Woods, Am. Perfumer Cosmet. 80(4): 51-53, 55-60 (1965), "Microcrystalline Cellulose, A New Ingredient for Pharmaceuticals and Cosmetics."
Atlas, Chem. Ind. Inc., 1969, 16 pp. "Atlas Mannitol N.F. A Definitive Guide to its Properties and Use as a Tablet Excipient."
Atlas, Chem. Ind. Inc., 1973, 16 pp. "Atlas Mannitol USP Tablet Excipient."

Affiliated with

Also associated with

Rating

Tablet formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tablet formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tablet formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1336888